Dubai stem cell treatments: 5 checks patients should make before paying

For patients in Dubai, the practical message from the latest discussion of stem cell conferences is simple: treat regenerative medicine as a regulated medical intervention, and ask for proof before paying AED 1.

The readers with most at stake are patients and families, medical directors, and clinic COOs. Patients need to separate approved treatment, research and marketing. In Dubai, the regulator to check is the Dubai Health Authority (DHA). In Abu Dhabi and Al Ain it is the Department of Health Abu Dhabi (DOH). In Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, it is the Ministry of Health and Prevention (MOHAP).

What patients should ask before booking

Stem cell medicine has one clear clinical home today: blood-forming stem cell transplantation for selected blood cancers, immune disorders and inherited blood diseases. Many other uses promoted online, including arthritis, chronic pain, anti-ageing, autism and neurological recovery, need a harder evidence check. The International Society for Stem Cell Research says stem cell treatments should be tested for safety and efficacy in regulated clinical trials before approval.

A Dubai patient should ask the clinic for five documents before paying a deposit:

• The facility licence showing the exact service approved by DHA, DOH or MOHAP.
• The treating doctor’s licence and specialty, matched to the condition being treated.
• A written diagnosis, eligibility note and reason for using cell therapy.
• The cell source, processing method, sterility testing and storage chain.
• A consent form stating known risks, uncertain benefits, follow-up visits and complaint route.

If the answer is a brochure, a testimonial or a package price, the patient has learned enough. A licensed clinic should be able to show the regulator, the protocol and the treating physician’s scope of practice. Patients should ask whether the treatment is standard care, an approved clinical trial, or a paid experimental intervention.

What UAE regulation changes in practice

MOHAP’s Cabinet Resolution No. 6 of 2020 sets rules for centres that handle umbilical cord blood, stem cells and other nucleated cells. For patients, cell collection, storage and use should sit inside a licensed, inspected healthcare framework.

Abu Dhabi has a visible specialist pathway. In March 2023, DOH appointed Abu Dhabi Stem Cells Center as a centre of excellence in stem cell transplantation. The Abu Dhabi Media Office said the centre had treated 13 cancer patients and one multiple sclerosis patient under the AD-BMT programme at that time. DOH standards also apply to licensed providers, health payers, researchers and suppliers involved in stem cell products and regenerative medicine.

Dubai patients should apply the same discipline. DHA licensing matters because many regenerative claims are sold in aesthetic, orthopaedic and longevity settings. A DHA-licensed facility may be licensed for one service and not another. Patients should verify the exact facility and professional licence through DHA’s Sheryan before treatment, then keep screenshots and written approvals.

Costs, insurance and red flags

There is no single public DHA tariff for commercial stem cell procedures across all indications. Patients should ask for a written quote that separates consultation, imaging, laboratory processing, theatre or procedure-room charges, medication, admission, follow-up and complication management. If insurance is involved, ask for written pre-authorisation before treatment. Major UAE payers such as Daman, Thiqa and Sukoon assess coverage by plan, diagnosis, network and medical necessity.

For self-pay patients, the usable number is the total exposure. A quote should state whether one session or multiple visits are expected, whether repeat injections are planned within three to 12 months, and who pays if infection, bleeding, admission or specialist referral follows. Patients should also ask whether the clinic reports outcomes to a registry or ethics committee.

Stem cell products are regulated, and most promoted uses remain unapproved or investigational. Patients should treat broad treatment claims as a warning sign. — Based on patient guidance from the International Society for Stem Cell Research and the US Food and Drug Administration

Dubai residents should walk away from any offer that promises cure rates, asks for immediate payment, discourages a second opinion, uses imported cells without documentation, or says a clinical trial listing is the same as treatment approval. A real clinical trial should have ethics approval, inclusion criteria, a named investigator and a consent process that explains alternatives.

Verify the clinic licence, confirm insurance in writing, ask for the protocol, and take the documents to an independent specialist before paying. For licensed pharmacy providers, use the UAE Open Healthcare Directory.